Fig. 5
From: Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer
Tryptase+/CPA3 + and Tryptase + cell subset expression in pre-and post-NACT HGSOC tumors. (A) intraepithelial and (B) stromal Tryptase+/CPA3 + mast cells in 29 matched pre- and post- NACT treated tumors. (C) total, (D) stomal, and (E) intraepithelial Tryptase + mast cells in 29 matched pre- and post- NACT treated tumors. Statistically significant differences determined by Student T-test. NACT, neoadjuvant chemotherapy, HGSOC, high grade serous ovarian cancer, * p < 0.05, ***p < 0.0005, ****p < 0.00005, as indicated, ns, non-significant